NEWS
3/9/23 11:15am
Elon University students relieved over 70% decrease in Eli Lilly insulin cost
Eli Lilly, Novo Nordisk and Sanofi own roughly 90% of the global insulin market. While costing less than $10 to manufacture, the average annual amount of out-of-pocket money that people with health coverage have to pay for insulin has more than doubled over the last two decades, according to Health System Tracker.
